(Q37987724)

26 August 2017

title

Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases (English)

1 reference

26 August 2017

main subject

cardiovascular disease

1 reference

Nathan D Roe

1

1 reference

26 August 2017

Jun Ren

series ordinal

2

1 reference

26 August 2017

publication date

16 February 2012

1 reference

26 August 2017

published in

Vascular Pharmacology

1 reference

26 August 2017

volume

57

1 reference

26 August 2017

issue

5-6

1 reference

26 August 2017

page(s)

168-172

1 reference

Neuronal nitric-oxide synthase mutant (Ser-1412 --> Asp) demonstrates surprising connections between heme reduction, NO complex formation, and catalysis

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Regulation of endothelial nitric oxide synthase by tetrahydrobiopterin in vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Arginase Reciprocally Regulates Nitric Oxide Synthase Activity and Contributes to Endothelial Dysfunction in Aging Blood Vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

S-glutathionylation uncouples eNOS and regulates its cellular and vascular function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Functional tetrahydrobiopterin synthesis in human platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Mechanistic insights into folic acid-dependent vascular protection: dihydrofolate reductase (DHFR)-mediated reduction in oxidant stress in endothelial cells and angiotensin II-infused mice: a novel HPLC-based fluorescent assay for DHFR activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

S-Nitrosylation of cardiac ion channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Signal transduction mechanisms involving nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Oxygen free radicals and calcium homeostasis in the heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Nitrogen oxide‐induced autoprotection in isolated rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

S-nitrosylation in cardiovascular signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Beneficial effects of exogenous tetrahydrobiopterin on left ventricular remodeling after myocardial infarction in rats: the possible role of oxidative stress caused by uncoupled endothelial nitric oxide synthase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

High-dose folic acid pretreatment blunts cardiac dysfunction during ischemia coupled to maintenance of high-energy phosphates and reduces postreperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Reversal of inducible nitric oxide synthase uncoupling unmasks tolerance to ischemia/reperfusion injury in the diabetic rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Angiotensin II activates NADPH oxidase in isolated rat hearts subjected to ischaemia-reperfusion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

S-nitrosation controls gating and conductance of the alpha 1 subunit of class C L-type Ca(2+) channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

IGF-I alleviates diabetes-induced RhoA activation, eNOS uncoupling, and myocardial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Inhibition of NADPH oxidase alleviates experimental diabetes-induced myocardial contractile dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Reduced vascular NO bioavailability in diabetes increases platelet activation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Regulation of tetrahydrobiopterin synthesis and bioavailability in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

The role of oxidative stress in the genesis of heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Reactive oxygen species in cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Mechanisms of the antioxidant effects of nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Role of reactive oxygen species in myocardial remodeling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2012.02.004

10.1016/J.VPH.2012.02.004

7 January 2021

Identifiers

DOI

1 reference

26 August 2017

1 reference